{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T03:37:41Z","timestamp":1772941061960,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["2010-047"],"award-info":[{"award-number":["2010-047"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.phrs.2012.12.004","type":"journal-article","created":{"date-parts":[[2012,12,28]],"date-time":"2012-12-28T14:46:37Z","timestamp":1356705997000},"page":"20-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Potential antipsoriatic effect of chondroitin sulfate through inhibition of NF-\u03baB and STAT3 in human keratinocytes"],"prefix":"10.1016","volume":"70","author":[{"given":"Rosa M.","family":"Andr\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Pay\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Carmen","family":"Montesinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia","family":"Ubeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Naval\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Verg\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Carmen","family":"Terencio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2012.12.004_bib0005","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-pathol-011811-132448","article-title":"Psoriasis","volume":"7","author":"Perera","year":"2012","journal-title":"Annual Review of Pathology"},{"key":"10.1016\/j.phrs.2012.12.004_bib0010","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.bcp.2004.05.039","article-title":"Regulation at multiple levels of NF-kappaB-mediated transactivation by protein acetylation","volume":"68","author":"Quivy","year":"2004","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.phrs.2012.12.004_bib0015","doi-asserted-by":"crossref","first-page":"32633","DOI":"10.1074\/jbc.M400642200","article-title":"Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling","volume":"279","author":"Banno","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.phrs.2012.12.004_bib0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/cr.2010.175","article-title":"NF-kappaB in the regulation of epithelial homeostasis and inflammation","volume":"21","author":"Wullaert","year":"2011","journal-title":"Cell Research"},{"key":"10.1016\/j.phrs.2012.12.004_bib0025","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.0022-202X.2005.23735.x","article-title":"Differential expression of phosphorylated NF-kappaB\/rela in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept","volume":"124","author":"Lizzul","year":"2005","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.phrs.2012.12.004_bib0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cca.2008.04.005","article-title":"Cytokines and anticytokines in psoriasis","volume":"394","author":"Pietrzak","year":"2008","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.phrs.2012.12.004_bib0035","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cyto.2011.09.007","article-title":"Ccl27 expression is regulated by both p38 MAPK and ikkbeta signalling pathways","volume":"56","author":"Riis","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.phrs.2012.12.004_bib0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nm0202-157","article-title":"Ccl27\u2013ccr10 interactions regulate t cell-mediated skin inflammation","volume":"8","author":"Homey","year":"2002","journal-title":"Nature Medicine"},{"key":"10.1016\/j.phrs.2012.12.004_bib0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cyto.2004.09.008","article-title":"Tumor necrosis factor-alpha-induced ctack\/ccl27 (cutaneous t-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB","volume":"29","author":"Vestergaard","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.phrs.2012.12.004_bib0050","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1365-2133.2007.08200.x","article-title":"Ctack\/ccl27 expression in psoriatic skin and its modification after administration of etanercept","volume":"157","author":"Campanati","year":"2007","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/j.phrs.2012.12.004_bib0055","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00109-009-0457-0","article-title":"IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not","volume":"87","author":"Wolk","year":"2009","journal-title":"Journal of Molecular Medicine (Berlin)"},{"key":"10.1016\/j.phrs.2012.12.004_bib0060","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1073\/pnas.86.16.6367","article-title":"Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes","volume":"86","author":"Grossman","year":"1989","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.phrs.2012.12.004_bib0065","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.4049\/jimmunol.178.4.2229","article-title":"The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis","volume":"178","author":"Sa","year":"2007","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.phrs.2012.12.004_bib0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm1162","article-title":"Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model","volume":"11","author":"Sano","year":"2005","journal-title":"Nature Medicine"},{"key":"10.1016\/j.phrs.2012.12.004_bib0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1749-6632.2009.04911.x","article-title":"Signal transducer and activator of transcription-3, inflammation, and cancer: How intimate is the relationship?","volume":"1171","author":"Aggarwal","year":"2009","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"Suppl. A","key":"10.1016\/j.phrs.2012.12.004_bib0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1063-4584(98)80004-6","article-title":"Chondroitin sulfate and joint disease","volume":"6","author":"Hardingham","year":"1998","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1016\/j.phrs.2012.12.004_bib0085","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1582-4934.2009.00826.x","article-title":"Immunomodulatory and anti-inflammatory effects of chondroitin sulphate","volume":"13","author":"du Souich","year":"2009","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.phrs.2012.12.004_bib0090","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/ard.2010.140848","article-title":"Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI","volume":"70","author":"Wildi","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"Suppl. 3","key":"10.1016\/j.phrs.2012.12.004_bib0095","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.joca.2008.06.006","article-title":"Clinical review of chondroitin sulfate in osteoarthritis","volume":"16","author":"Uebelhart","year":"2008","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1016\/j.phrs.2012.12.004_bib0100","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2003.011742","article-title":"Eular recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the standing committee for international clinical studies including therapeutic trials (escisit)","volume":"62","author":"Jordan","year":"2003","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.phrs.2012.12.004_bib0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5070\/D32ZH8X3VF","article-title":"Clinical and histopathological improvement of psoriasis with oral chondroitin sulfate: a serendipitous finding","volume":"11","author":"Verges","year":"2005","journal-title":"Dermatology Online Journal"},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2012.12.004_bib0110","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.joca.2010.01.018","article-title":"Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study","volume":"18","author":"Moller","year":"2010","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1016\/j.phrs.2012.12.004_bib0115","first-page":"83","article-title":"Cultivation, frozen storage, and clonal growth of normal human epidermal keratinocytes in serum-free media","volume":"9","author":"Boyce","year":"1985","journal-title":"Methods in Cell Science"},{"key":"10.1016\/j.phrs.2012.12.004_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0887-2333(88)90030-6","article-title":"Comparisons of two in vitro cytotoxicity assays \u2013 the neutral red (NR) and tetrazolium MTT tests","volume":"2","author":"Borenfreund","year":"1988","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.phrs.2012.12.004_bib0125","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/jm0700823","volume":"50","author":"Guerrero","year":"2007","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.phrs.2012.12.004_bib0130","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.4049\/jimmunol.174.3.1686","article-title":"Protein kinase c alpha-mediated chemotaxis of neutrophils requires NF-kappa B activity but is independent of TNF alpha signaling in mouse skin in vivo","volume":"174","author":"Cataisson","year":"2005","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.phrs.2012.12.004_bib0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1742-7843.2007.00158.x","article-title":"Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-kappaB in interleukin-1beta-stimulated chondrocytes","volume":"102","author":"Jomphe","year":"2008","journal-title":"Basic and Clinical Pharmacology and Toxicology"},{"key":"10.1016\/j.phrs.2012.12.004_bib0140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/jid.2010.255","article-title":"Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with sta-21, a stat3 inhibitor","volume":"131","author":"Miyoshi","year":"2011","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.phrs.2012.12.004_bib0145","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.neuroscience.2010.02.069","article-title":"Chondroitin sulfate inhibits lipopolysaccharide-induced inflammation in rat astrocytes by preventing nuclear factor kappa B activation","volume":"167","author":"Canas","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2012.12.004_bib0150","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.joca.2008.04.002","article-title":"Chondroitin-4-sulphate inhibits NF-kb translocation and caspase activation in collagen-induced arthritis in mice","volume":"16","author":"Campo","year":"2008","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1016\/j.phrs.2012.12.004_bib0155","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-kappaB. A key role in inflammatory diseases","volume":"107","author":"Tak","year":"2001","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.phrs.2012.12.004_bib0160","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.4049\/jimmunol.175.4.2721","article-title":"TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques","volume":"175","author":"Gottlieb","year":"2005","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.phrs.2012.12.004_bib0165","doi-asserted-by":"crossref","first-page":"9667","DOI":"10.1021\/jf801578x","article-title":"Chondroitin sulfate extracted from Ascidian tunic inhibits phorbol ester-induced expression of inflammatory factors vcam-1 and cox-2 by blocking NF-kappaB activation in mouse skin","volume":"56","author":"Xu","year":"2008","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"10.1016\/j.phrs.2012.12.004_bib0170","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/cr.2009.137","article-title":"The nuclear signaling of NF-kappaB: current knowledge, new insights, and future perspectives","volume":"20","author":"Wan","year":"2010","journal-title":"Cell Research"},{"key":"10.1016\/j.phrs.2012.12.004_bib0175","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.0022-202X.2005.23749.x","article-title":"Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin","volume":"124","author":"Johansen","year":"2005","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.phrs.2012.12.004_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2007.05.016","article-title":"Impact of stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases","volume":"50","author":"Sano","year":"2008","journal-title":"Journal of Dermatological Science"},{"key":"10.1016\/j.phrs.2012.12.004_bib0185","doi-asserted-by":"crossref","first-page":"pe61","DOI":"10.1126\/scisignal.290pe61","article-title":"Stat3 revs up the powerhouse","volume":"2","author":"Reich","year":"2009","journal-title":"Science Signaling"},{"key":"10.1016\/j.phrs.2012.12.004_bib0190","doi-asserted-by":"crossref","first-page":"e20188","DOI":"10.1371\/journal.pone.0020188","article-title":"Dynamics of the stat3 transcription factor: nuclear import dependent on ran and importin-beta1","volume":"6","author":"Cimica","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2012.12.004_bib0195","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1073\/pnas.0501643102","article-title":"Stat3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3","volume":"102","author":"Liu","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.phrs.2012.12.004_bib0200","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1053\/joca.2002.0824","article-title":"Oral bioavailability of chondroitin sulfate (condrosulf) and its constituents in healthy male volunteers","volume":"10","author":"Volpi","year":"2002","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1016\/j.phrs.2012.12.004_bib0205","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1063-4584(03)00051-7","article-title":"Oral absorption and bioavailability of ichthyic origin chondroitin sulfate in healthy male volunteers","volume":"11","author":"Volpi","year":"2003","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1016\/j.phrs.2012.12.004_bib0210","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.0022-202X.2004.22316.x","article-title":"Human single-chain antibodies reactive with native chondroitin sulfate detect chondroitin sulfate alterations in melanoma and psoriasis","volume":"122","author":"Smetsers","year":"2004","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.phrs.2012.12.004_bib0215","doi-asserted-by":"crossref","first-page":"c4675","DOI":"10.1136\/bmj.c4675","article-title":"Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis","volume":"341","author":"Wandel","year":"2010","journal-title":"British Medical Journal"},{"key":"10.1016\/j.phrs.2012.12.004_bib0220","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/1874312901206010183","article-title":"Symptom-modifying effect of chondroitin sulfate in knee osteoarthritis: a meta-analysis of randomized placebo-controlled trials performed with Structum\u00ae","volume":"6","author":"Schneider","year":"2012","journal-title":"Open Rheumatology Journal"},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2012.12.004_bib0225","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.joca.2010.02.016","article-title":"Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration","volume":"18","author":"Hochberg","year":"2010","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1016\/j.phrs.2012.12.004_bib0230","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.joca.2004.01.004","article-title":"Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo","volume":"12","author":"Uebelhart","year":"2004","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1016\/j.phrs.2012.12.004_bib0235","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa052771","article-title":"Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis","volume":"354","author":"Clegg","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.phrs.2012.12.004_bib0240","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nm0512-638","article-title":"New biologic drugs get under the skin of psoriasis","volume":"18","author":"Williams","year":"2012","journal-title":"Nature Medicine"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366181200240X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366181200240X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T10:44:30Z","timestamp":1772880270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366181200240X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S104366181200240X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2012.12.004","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential antipsoriatic effect of chondroitin sulfate through inhibition of NF-\u03baB and STAT3 in human keratinocytes","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2012.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}